Analytical method development and validation of Amlodipine besylate in tablet dosage form
The accurate and precise HPLC analytical method validated for the determination of Amlodipine besylate in pharmaceutical dosage form. The chromatographic separation is carried out on shimadzu HPLC system (LC-2010 CHT) with UV Vissible detector and C18(150mm x3.9 mm) 5 μm Column. The Mobile phase consists of Acetonitrile: Methanol: PH 3.0 Buffer (15 V: 35 V: 50 V) , at the flow rate of 1.0 ml/min and elutes were monitoring at 237 nm. The observed retention time for Amlodipine besylate was 12.3 min. The % RSD for system precision was 0.41 % and Method precision was 0.58 %. The method was found to linear (R=0.99996) in the Concentration range of 35-105 μg/ml (50 to 150%). The accuracy was in between 99.50-99.91%.
Keywords: HPLC, Correlation coefficient, System suitability, Bias, % RSD and ICH guidelines
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).